Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment.
Given an increasing number of patients with congestive heart failure (CHF) refractory to diuretics, new and more effective therapeutic modalities are sought. Peritoneal dialysis (PD), which provides continuous, slow ultrafiltration, may be an alternative to hemodialysis in this population. The current paper, based on a comprehensive literature review, addresses the role of PD in improving the quality of life of patients with CHF.
Próchnicka
Agnieszka
A
Department of Internal Diseases, Nephrology and Dialysis, Military Medicine Institute, Central Hospital, Ministry of National Defence, Warszawa, Poland. a.borkowska4@wp.pl
Olszowska
Anna
A
Baczyński
Daniel
D
Zelichowski
Grzegorz
G
Wańkowicz
Zofia
Z
D004351:Drug Resistance; D005919:Glomerular Filtration Rate; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D015312:Hemodialysis Solutions / Q000008:administration & dosage*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D010530:Peritoneal Dialysis / Q000379:methods*; D011788:Quality of Life; D013318:Stroke Volume; D016896:Treatment Outcome; D014882:Water-Electrolyte Balance
D015312:Hemodialysis Solutions